 "Sputnik V, Dr Reddy's Laboratories, DRL, coronavirus, vaccine, covid-19")
Shares of Dr Reddy’s Laboratories moved higher by 8 per cent to Rs 5,119.90 on the BSE in intra-day trade on Monday after Sputnik-V, the vaccine against the coronavirus disease (Covid-19), got nod from the expert panel for emergency use in India. READ ABOUT IT HERE
This is the third vaccine approved by India after Covishield and Covaxin. The stock finally settled 5 per cent higher at Rs 4,989, as compared to 3.4 per cent fall in the S&P BSE Sensex.
In February, Dr Reddy’s had announced that the company has initiated the process with the
This is the third vaccine approved by India after Covishield and Covaxin. The stock finally settled 5 per cent higher at Rs 4,989, as compared to 3.4 per cent fall in the S&P BSE Sensex.
In February, Dr Reddy’s had announced that the company has initiated the process with the
